Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications
Authors
Keywords
-
Journal
Journal of Diabetes Investigation
Volume 3, Issue 2, Pages 107-114
Publisher
Wiley
Online
2012-01-27
DOI
10.1111/j.2040-1124.2011.00191.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RAGE Ligation Affects T Cell Activation and Controls T Cell Differentiation
- (2014) Y. Chen et al. JOURNAL OF IMMUNOLOGY
- RAGE biology, atherosclerosis and diabetes
- (2011) Drazenka Pongrac Barlovic et al. CLINICAL SCIENCE
- Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
- (2011) H. M. Colhoun et al. DIABETES
- Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes
- (2011) M. C. Thomas et al. DIABETOLOGIA
- Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells
- (2011) Mei He et al. EMBO REPORTS
- Regulation of RAGE for Attenuating Progression of Diabetic Vascular Complications
- (2011) Myat Thu Thu Win et al. Experimental Diabetes Research
- Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
- (2011) Y. Yamamoto et al. JOURNAL OF IMMUNOLOGY
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
- (2011) Goodarz Danaei et al. LANCET
- AGE restriction in diabetes mellitus: a paradigm shift
- (2011) Helen Vlassara et al. Nature Reviews Endocrinology
- TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
- (2011) Masakiyo Sakaguchi et al. PLoS One
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes
- (2010) Xystus H. L. Tam et al. CLINICAL SCIENCE
- Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
- (2010) J. Li et al. DIABETES
- Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
- (2010) Nina Reiniger et al. DIABETES
- Carboxylated N-glycans on RAGE promote S100A12 binding and signaling
- (2010) Geetha Srikrishna et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- sRAGE Induces Human Monocyte Survival and Differentiation
- (2010) Y. Wang et al. JOURNAL OF IMMUNOLOGY
- Mechanism of diabetic neuropathy: Where are we now and where to go?
- (2010) Soroku Yagihashi et al. Journal of Diabetes Investigation
- Advanced Glycation End Product Receptor-1 Transgenic Mice Are Resistant to Inflammation, Oxidative Stress, and Post-Injury Intimal Hyperplasia
- (2009) Massimo Torreggiani et al. AMERICAN JOURNAL OF PATHOLOGY
- RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice
- (2009) L. Sun et al. CARDIOVASCULAR RESEARCH
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- TRC4186, a Novel AGE-breaker, Improves Diabetic Cardiomyopathy and Nephropathy in Ob-ZSF1 Model of Type 2 Diabetes
- (2009) Deepa Joshi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products
- (2009) Y.-H. Qin et al. JOURNAL OF IMMUNOLOGY
- Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic Atherosclerosis
- (2008) Conrad P. Hodgkinson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes
- (2008) Naoto Katakami et al. ATHEROSCLEROSIS
- Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress
- (2008) Naila Rabbani et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Solution Structure of the Variable-Type Domain of the Receptor for Advanced Glycation End Products: New Insight into AGE−RAGE Interaction†,‡
- (2008) Shigeyuki Matsumoto et al. BIOCHEMISTRY
- Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
- (2008) A. Soro-Paavonen et al. DIABETES
- A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
- (2008) Angela Raucci et al. FASEB JOURNAL
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now